Table 1.

Clinical characteristics of all 102 lung cancer patients.

Characteristic	Data
No. of patients	102
Age (years) Mean ± SD (range; median)	58.37 ± 10.51 (30–80; 59.50)
Gender
Male	41 (40.2%)
Female	61 (59.8%)
Smoke status
Never smoker	76 (74.5%)
Smoker	26 (25.5%)
Histology
entire ADC	88 (86.3%)
partial ADC	14 (13.7%)
TNM stage
III	23 (22.5%)
IV	79 (77.5%)
Drug
Icotinib	21 (20.6%)
Erlotinib	15 (14.7%)
Gefitinib	66 (64.7%)
PLR Mean ± SD (range; median)	175.31 ± 90.05 (60.85–748.57; 156.11)
MLR Mean ± SD (range; median)	0.33 ± 0.23 (0.11–1.75; 0.26)
NLR Mean ± SD (range; median)	3.41 ± 1.67 (0.98–8.33; 2.95)
SII Mean ± SD (range; median)	855.31 ± 560.89 (130.21–3480.86; 712.76)
PFS (months) Median/Mean ± SD	11.00/12.79 ± 10.74
OS (months) Median/Mean ± SD	20.05/22.63 ± 13.03